Autoimmune Diseases of the Nervous System: all 114 studies
Page 1 of 2. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Clinical Evaluation of a Novel DAB Chromogenic Tissue-Based Assay for Detecting Anti-GABABR AntibodiesNot yet recruitingNCT07858175
- Efgartigimod in Anti-NMDA Receptor Encephalitis.RecruitingNCT07822776Phase 2
- A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune DiseaseNot yet recruitingNCT07804004Phase 1/2
- Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric DiseasesNot yet recruitingNCT07791212
- A Basket Study of CTA313 in Participants With Active Autoimmune DiseasesNot yet recruitingNCT07783269Phase 1
- AXIS MG Patient RegistryRecruitingNCT07761026
- Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyRecruitingNCT07759115Not applicable
- Plasma Exchange in Pediatric Autoimmune EncephalitisRecruitingNCT07707739Not applicable
- OPM- MEG in Non-immune And iMmune-medIated Neurological DiseaseRecruitingNCT07689682Not applicable
- Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune CerebellitisNot yet recruitingNCT07686042Phase 4
- Cohort Study on Neuroimmune Diseases in the Reproductive AgeRecruitingNCT07653984
- A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and AdultsNot yet recruitingNCT07583641Phase 2
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.RecruitingNCT07526493Phase 1
- Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?RecruitingNCT07488117Phase 2
- Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune EncephalitisRecruitingNCT07477015
- A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard TherapyNot yet recruitingNCT07341828Phase 1
- CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune DiseasesRecruitingNCT07337785Early Phase 1
- Tongji NADs CohortNot yet recruitingNCT07333196
- Medium-term Effects of Treatments in Autoimmune EncephalitisRecruitingNCT07133113
- hUC-MSC-Exo Therapy for Autoimmune EncephalitisNot yet recruitingNCT07131683Phase 1/2
- A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric DiseaseRecruitingNCT07093333Phase 2
- Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune DiseasesRecruitingNCT06939166Early Phase 1
- Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune EncephalitisRecruitingNCT06867991Phase 3
- High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell NetworkRecruitingNCT06863974Not applicable
- JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune DisordersRecruitingNCT06797024Not applicable
- A Multicentric Cohort of Autoimmune EncephalitisNot yet recruitingNCT06760091
- Risk Prediction Model for Severe Autoimmune EncephalitisNot yet recruitingNCT06697678
- Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related DiseasesRecruitingNCT06626919Phase 1
- Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)RecruitingNCT06584045Not applicable
- Biomarkers in Autoimmune Disease of Nervous SystemRecruitingNCT06502015
- Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.Not yet recruitingNCT06485232Early Phase 1
- Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU TreatmentNot yet recruitingNCT06456736
- National, Multicentric Registry Study on Neuroimmunological Diseases in ChinaRecruitingNCT06443333
- Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown EtiologyRecruitingNCT06388161
- Brain MRI Longitudinal Volumetric Characteristics Associated With Outcomes of CASPR2-Limbic EncephalitisRecruitingNCT06245447
- A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 EncephalitisRecruitingNCT06173076
- Impact of Confirmed Autoimmune Encephalitis on Brain Glucose MetabolismRecruitingNCT06079294Not applicable
- FDG-PET in the Diagnosis of Autoimmune EncephalitisRecruitingNCT06019975
- Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MSRecruitingNCT05834855Phase 3
- Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological SyndromesRecruitingNCT05772611
- Predicting and Monitoring Outcomes in Autoimmune EncephalitisNot yet recruitingNCT05711563
- Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated EpilepsyEnrolling by invitationNCT05422664
- Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)RecruitingNCT05418010Phase 2
- Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune EncephalitisRecruitingNCT05280600
- GWAS in NMDAR EncephalitisRecruitingNCT05225883
- Predictors and Prognostic Factors of Myasthenia Gravis OutcomeRecruitingNCT05214612
- MS-ResearchBiomarkerSRecruitingNCT05204459
- Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis CollectionRecruitingNCT05198661Not applicable
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)RecruitingNCT05017142
- HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part IIRecruitingNCT04823728
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruitingNCT04806620
- Pathogenicity of B and CD4 T Cell Subsets in Multiple SclerosisRecruitingNCT04798651Not applicable
- Collection of Biological Samples From Patients With Rare Neurological DiseasesRecruitingNCT04698421
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemRecruitingNCT04561557Early Phase 1
- The ExTINGUISH Trial of Inebilizumab in NMDAR EncephalitisRecruitingNCT04372615Phase 2
- Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune EncephalitisRecruitingNCT03993262Phase 2
- Aerobic Exercise for Remyelination in Multiple SclerosisCompletedNCT04539002Not applicableResults posted
- Efficacy of Ocrelizumab in Autoimmune EncephalitisTerminatedNCT03835728Phase 2Results posted
- IVIG Treatment for Refractory Immune-Related Adult EpilepsyTerminatedNCT01545518Phase 2Results posted
- Relapse and Functional Outcomes in Anti-LGI1 EncephalitisCompletedNCT07722286
- Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory SyndromesActive, not recruitingNCT07145502
- Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or EncephalomyelitisCompletedNCT07036042
- Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières SyndromeCompletedNCT06898372
- Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy ParticipantsCompletedNCT06753955Phase 1
- PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPFCompletedNCT06683612Phase 1
- IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple SclerosisSuspendedNCT06677710Phase 1
- Long-term Impact of NMDAR EncephalitisCompletedNCT06609044
- Phase 1 Study of ART5803 in Healthy ParticipantsCompletedNCT06575153Phase 1
- Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiSActive, not recruitingNCT06432803
- A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkActive, not recruitingNCT06290128Phase 3
- Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune EncephalitisCompletedNCT06033846Phase 2
- Exploring Outcomes and Characteristics of Myasthenia Gravis 2CompletedNCT06002945
- Psycho-social Impact of Anti-NMDAR EncephalitisCompletedNCT05954468
- Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune OriginActive, not recruitingNCT05953974
- The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia GravisCompletedNCT05917184
- Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And NeurodegenerationActive, not recruitingNCT05893225Phase 2
- BRIEF TITLE * (in English and Sufficiently Descriptive) Role of MRI in Anti-LGI1 EncephalitisCompletedNCT05825690
- Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility StudyCompletedNCT05792176Not applicable
- Diagnostic Performance of a Commercial Assay for the Detection of Neuronal AntibodiesCompletedNCT05783947
- Long-term Follow up of Patient With Anti-GABAbr Antibodies Associated-encephalitis.CompletedNCT05741619
- New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic SyndromesActive, not recruitingNCT05728931
- Therapies for Down Syndrome Regression DisorderCompletedNCT05662228Phase 2
- Characterisation of Clinical Phenotypes and Outcomes of Ma2 PatientCompletedNCT05645185
- Telerehabilitation of Multidomain Cognitive Impairment in Multiple SclerosisTerminatedNCT05611047Not applicable
- Study of Acute Autoimmune Encephalitis With Positive Antibodies in Eastern FranceCompletedNCT05605223
- Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen DeterminationStatus unknownNCT05414890
- Phase III Clinical Study of NPB-01 in Patients With Autoimmune EncephalitisStatus unknownNCT05177939Phase 3
- Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or NatalizumabCompletedNCT04837651
- Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple SclerosisCompletedNCT04786821Not applicable
- Power Training in Older Multiple Sclerosis PatientsStatus unknownNCT04762342Not applicable
- Inhibition of Reverse Transcription in Aicardi-Goutières SyndromeCompletedNCT04731103Phase 2
- Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in SwedenCompletedNCT04708626
- Diffusion Imaging in Acute Auto-immune EncephalitisStatus unknownNCT04339205
- Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic EncephalitisStatus unknownNCT04339127
- Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:CompletedNCT04175522Phase 2
- HLA Analysis in Autoimmune Encephalitis and Related DisordersStatus unknownNCT04106596
- Incidence of Paraneoplastic Neurological Syndromes and Autoimmune EncephalitisStatus unknownNCT03957616
- Neuro-ophthalmology and Autoimmune Encephalitis (NODE)CompletedNCT03872284
- Cognition and MRI Markers in MS Patients With Aubagio® TreatmentCompletedNCT03768648Not applicable
- CPI Combination Therapy for Autoimmune EncephalitisCompletedNCT03542279Not applicable